(Q28192599)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909559%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

review article

1 reference

title

Relative risk of cardiovascular events in patients with rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909559%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

1 reference

Anthony N DeMaria

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909559%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

English

0 references

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909559%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909559%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909559%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

6A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909559%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

33D-38D

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909559%20AND%20SRC:MED&resulttype=core&format=json

The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet Activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

The epidemiology of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Epidemiology of rheumatic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Hormonal alterations in rheumatoid arthritis, including the effects of pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Comorbidity and lifestyle, reproductive factors, and environmental exposures associated with rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Formal education level as a significant marker of clinical status in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

What happens to patients with rheumatoid arthritis? The long-term outcome of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

The mortality of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Mortality in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Total mortality is increased in rheumatoid arthritis. A 17-year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Survival study of rheumatoid arthritis patients in Madrid (Spain). A 9-year prospective follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Comorbidity in rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Cardiovascular mortality in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Cause of death in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

C-reactive protein, cardiovascular risk factors and the association with myocardial infarction in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Direct proinflammatory effect of C-reactive protein on human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Enhanced Inflammatory Response to Coronary Angioplasty in Patients With Severe Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Perturbation of the T-Cell Repertoire in Patients With Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

A tale of two diseases: atherosclerosis and rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

NSAIDs and increased blood pressure. What is the clinical significance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

NSAIDs and blood pressure. Clinical importance for older patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

The impact of nonsteroidal anti-inflammatory drugs on hypertension: alternative analgesics for patients at risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Effect of short-term aspirin use on C-reactive protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

AHA Scientific Statement. Supplement to the guidelines for the management of transient ischemic attacks: A statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

Cyclooxygenase inhibition and thrombogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902235-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(02)02235-X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909559%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference